Zymeworks (ZYME) Retained Earnings (2021 - 2026)
Zymeworks (ZYME) reported Retained Earnings of -$6.6 million for Q1 2026, down 2.48% on a YoY basis from -$6.7 million in Q1 2025, and down 7.99% sequentially from -$6.1 million in Q4 2025.
Zymeworks (ZYME) Retained Earnings (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Retained Earnings data on file, last reported at -$6.6 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 2.48% year-over-year to -$6.6 million; the trailing twelve-month figure through Mar 2026 stood at -$6.6 million (down 2.48% YoY), and the FY2025 full-year result was -$6.1 million, up 99.27% from the prior year.
- Retained Earnings eased to -$6.6 million in Q1 2026, from -$6.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$5.9 million in Q1 2023 to a low of -$868.2 million in Q3 2022.
- A 5-year average of -$291.7 million and a median of -$7.7 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings tumbled 8291.09% in 2022 and soared 99.27% in 2025, its largest moves.
- Tracing ZYME's Retained Earnings over 5 years: stood at -$558.8 million in 2022, then slipped by 21.24% to -$677.4 million in 2023, then fell by 22.57% to -$830.3 million in 2024, then soared by 99.27% to -$6.1 million in 2025, then retreated by 7.99% to -$6.6 million in 2026.
- Business Quant data shows ZYME's Retained Earnings at -$6.6 million in Q1 2026, -$6.1 million in Q4 2025, and -$6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -6.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.57 Mn |
| Dec 31, 2025 | -6.08 Mn |
| Sep 30, 2025 | -6.05 Mn |
| Jun 30, 2025 | -6.34 Mn |
| Mar 31, 2025 | -6.41 Mn |
| Dec 31, 2024 | -830.34 Mn |
| Sep 30, 2024 | -6.00 Mn |
| Jun 30, 2024 | -746.78 Mn |
| Mar 31, 2024 | -7.72 Mn |
| Dec 31, 2023 | -677.44 Mn |
| Sep 30, 2023 | -8.30 Mn |
| Jun 30, 2023 | -634.27 Mn |
| Mar 31, 2023 | -5.94 Mn |
| Dec 31, 2022 | -558.76 Mn |
| Sep 30, 2022 | -868.19 Mn |
| Dec 31, 2021 | -6.66 Mn |